Transplacental transfer of monomethyl phthalate and mono(2-ethylhexyl) phthalate in a human placenta perfusion system

International Journal of Toxicology

Volumn 26, Issue 3, 2007, Pages 221-229

  Mose, Tina ^a,c   Knudsen, Lisbeth E ^a   Hedegaard, Morten ^b   Mortensen, Gerda K ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c NONE   (Denmark)

Author keywords

Exposure; Fetal; mEHP; mMP; Perfusion; Placenta

Indexed keywords

PHTHALIC ACID 2 ETHYLHEXYL MONOESTER; PHTHALIC ACID DIMETHYL ESTER;

ARTICLE; CESAREAN SECTION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); COTYLEDON; FETOPLACENTAL UNIT; FETUS CIRCULATION; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATERNAL BLOOD; PLACENTA; PLACENTA PERFUSION; PLACENTAL TRANSFER; TISSUE LEVEL; UMBILICAL CORD BLOOD;

DIETHYLHEXYL PHTHALATE; FEMALE; FETAL BLOOD; HUMANS; MATERNAL-FETAL EXCHANGE; MODELS, BIOLOGICAL; PERFUSION; PHTHALIC ACIDS; PLACENTA; PREGNANCY;

EID: 34250358170     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810701352721     Document Type: Article

References (47)

1. Adibi, J. J., F. P. Perera, W. Jedrychowski, D. E. Camann, D. Barr, R. Jacek, and R. M. Whyatt. 2003. Prenatal exposures to phthalates among women in New York City and Krakow, Poland. Environ. Health Perspect. 111:1719-1722.
2. Audus, K. L. 1999. Controlling drug delivery across the placenta. Eur. J. Pharm. Sci. 8:161-165.
3. Barr, D. B., M. J. Silva, K. Kato, J. A. Reidy, N. A. Malek, D. Hurtz, M. Sadowski, L. L. Needham, and A. M. Calafat. 2003. Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers. Environ. Health Perspect. 111:1148-1151.
4. Becker, K., M. Seiwert, J. Angerer, W. Heger, H. M. Koch, R. Nagorka, E. Rosskamp, C. Schluter, B. Seifert, and D. Ullrich. 2004. DEHP metabolites in urine of children and DEHP in house dust. Int. J. Hyg. Environ. Health. 207:409-417.
5. Cobellis, L., G. Latini, F. C. De, S. Razzi, I. Paris, F. Ruggieri, P. Mazzeo, and F. Petraglia. 2003. High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. Hum. Reprod. 18:1512-1515.
6. Collier, A. C., J. A. Leelan, P. E. Van Zijl, J. W. Paxton, M. D. Mitchell, and M. D. Tingle. 2004. Human placental glucuronidation and transport of 3′-azido-3′-deoxythymidine and uridine diphosphate glucuronic acid. Drug Metabol. Disp. 32:813-820.
7. Colon, I., D. Caro, C. J. Bourdony, and O. Rosario. 2000. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ. Health Perspect. 108:895-900.
8. Duty, S. M., R. M. Ackerman, A. M. Calafat, and R. Hauser. 2005. Personal care product use predicts urinary concentrations of some phthalate monoesters. Environ. Health Perspect. 113:1530-1535.
9. Duty, S. M., A. M. Calafat, M. J. Silva, J. W. Brock, L. Ryan, Z. Chen, J. Overstreet, and R. Hauser. 2004. The relationship between environmental exposure to phthalates and computer-aided sperm analysis motion parameters. J. Androl. 25:293-302.
10. Duty, S. M., N. P. Singh, M. J. Silva, D. B. Barr, J. W. Brock, L. Ryan, R. F. Herrick, D. C. Christiani, and R. Hauser. 2003. The relationship between environmental exposures to phthalates and DNA damage in human sperm using the neutral comet assay. Environ. Health Perspect. 111:1164-1169.
11. Ema, M., and E. Miyawaki. 2001. Effects of monobutyl phthalate on reproductive function in pregnant and pseudopregnant rats. Reprod. Toxicol. 15:261-267.
12. Ganapathy, V., and P. D. Prasad. 2005. Role of transporters in placental transfer of drugs. Toxicol. Appl. Pharmacol. 207(2 suppl):381-387.
13. Ganapathy, V., P. D. Prasad, M. E. Ganapathy, and F. H. Leibach. 2000. Placental transporters relevant to drug distribution across the maternal-fetal interface. J. Pharmacol. Exp. Ther. 294:413-420.
14. Gray, L. E., Jr., J. Ostby, J. Furr, M. Price, D. N. Veeramachaneni, and L. Parks. 2000. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol. Sci. 58:350-365.
15. Hakkola, J., M. Pasanen, J. Hukkanen, O. Pelkonen, J. Maenpaa, R. J. Edwards, A. R. Boobis, and H. Raunio. 1996. Expression of xenobiotic- metabolizing cytochrome P450 forms in human full-term placenta. Biochem. Pharmacol. 51:403-411.
16. Hakkola, J., O. Pelkonen, M. Pasanen, and H. Raunio. 1998. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: Role in intrauterine toxicity. Crit. Rev. Toxicol. 28:35-72.
17. Jacobson, R. L., A. Brewer, A. Eis, T. A. Siddiqi, and L. Myatt. 1991. Transfer of aspirin across the perfused human placental cotyledon. Am. J. Obstet. Gynecol. 165:939-944.
18. Jarfelt, K., M. Dalgaard, U. Hass, J. Borch, H. Jacobsen, and O. Ladefoged. 2005. Antiandrogenic effects in male rats perinatally exposed to a mixture of di(2-ethylhexyl) phthalate and di(2-ethylhexyl) adipate. Reprod. Toxicol. 19:505-515.
19. Kato, K., M. J. Silva, J. A. Reidy, D. Hurtz, N. A. Malek, L. L. Needham, H. Nakazawa, D. B. Barr, and A. M. Calafat. 2004. Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. Environ. Health Perspect. 112:327-330.
20. Kihlstrom, I. 1983. Placental transfer of diethylhexyl phthalate in the guinea-pig placenta perfused in situ. Acta Pharmacol. Toxicol. (Copenh). 53:23-27.
21. Koch, H. M., H. M. Bolt, R. Preuss, and J. Angerer. 2005. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Arch. Toxicol. 79:367-376.
22. Koch, H. M., R. Preuss, and J. Angerer. 2006. Di(2-ethylhexyl)phthalate (DEHP): Human metabolism and internal exposure - An update and latest results. Int. J. Androl. 29:155-165.
23. Lashley, S., A. Calafat, D. Barr, and T. Ledoux. 2006. Endocrine disruptors in maternal and fetal compartments. Am. J. Obstet. Gynecol. 191(6 suppl):140.
24. Latini, G., C. De Felice, G. Presta, A. Del Vecchio, I. Paris, F. Ruggieri, and P. Mazzeo. 2003a. Exposure to Di(2-ethylhexyl)phthalate in humans during pregnancy. A preliminary report. Biol. Neonate 83:22-24.
25. Latini, G., C. De Felice, G. Presta, A. Del Vecchio, I. Paris, F. Ruggieri, and P. Mazzeo. 2003b. In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. Environ. Health Perspect. 111:1783-1785.
26. Lottrup, G., A.-M. Andersson, H. Leffers, G. K. Mortensen, J. Toppari, N. E. Skakkebaek, and K. M. Main. 2006. Possible impact of phthalates on infant reproductive health. Int. J. Androl. 29:172-180.
27. Main, K. M., G. K. Mortensen, M. M. Kaleva, K. A. Boisen, I. N. Damgaard, M. Chellakooty, I. M. Schmidt, A.-M. Supmi, H. E. Virtanen, J. H. Petersen, A.-M. Andersson, J. Toppari, and N. E. Skakkebaek. 2006. Human breast milk contamination with phthalates and alteration of endogenous reproductive hormones in three months old infants. Environ. Health Perspect. 114:270-276. doi:10.1289/ehp.8075 available via http://dx.doi.org/.
28. Mortensen, G. K., K. M. Main, A.-M. Andersson, H. Leffers, and N. E. Skakkebaek. 2005. Determination of phthalate monoesters in human milk, consumer milk, and infant formula by tandem mass spectrometry (LC-MS-MS). Anal. Bioanal. Chem. 382:1084-1092.
29. Mose, T., and L. E. Knudsen. 2006. Placenta perfusion - Human alternative. Altern. Anim. Exp. 23:358-363.
30. Mose, T., G. K. Mortensen, M. Hedegaard, and L. E. Knudsen. 2007. Phthalate monoesters in perfusate from a dual placenta perfusion system, the placenta and umbilical cord blood. Reprod. Toxicol. 23:83-91. http://dx.doi.org/10.1016/j.reprotox.2006.08.006. Accessed 2007.
31. National Center for Environmental Health, Department of Health and Human Services CfDCaP. 2005. Third National Report on Human Exposure to Environmental Chemicals. 3, 1-475. Atlanta, GA: Division of Laboratory Sciences.
32. Pacifici, G. M., and R. Nottoli. 1995. Placental transfer of drugs administered to the mother. Clin. Pharmacokinet. 28:235-269.
33. Pasanen, M. 1999. The expression and regulation of drug metabolism in human placenta. Adv. Drug Deliv. Rev. 38:81-97.
34. Pasanen, M., and O. Pelkonen. 1994. The expression and environmental regulation of P450 enzymes in human placenta. Crit. Rev. Toxicol. 24:211-229.
35. Poole, C. F., and D. G. Wibberley. 1977. Determination of di-(2-ethylhexyl)phthalate in human placenta. J. Chromatogr. 132:511-518.
36. Preuss, R., H. M. Koch, and J. Angerer. 2005. Biological monitoring of the five major metabolites of di-(2-ethylhexyl)phthalate (DEHP) in human urine using column-switching liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 816:269-280.1
37. Saillenfait, A. M., J. P. Payan, J. P. Fabry, D. Beydon, I. Langonne, F. Gallissot, and J. P. Sabate. 1998. Assessment of the developmental toxicity, metabolism, and placental transfer of di-n-butyl phthalate administered to pregnant rats. Toxicol. Sci. 45:212-224.
38. Schenker, S., Y. Yang, D. Mattiuz, and M. Lee. 1999. Olanzapine transfer by human placenta. Clin. Exp. Pharm. Physiol. 26:691-697.
39. Silva, M. J., D. B. Barr, J. A. Reidy, K. Kato, N. A. Malek, C. C. Hodge, D. Hurtz, III, A. M. Calafat, L. L. Needham, and J. W. Brock. 2003. Glucuronidation patterns of common urinary and serum monoester phthalate metabolites. Arch. Toxicol. 77:561-567.
40. Silva, M. J., D. B. Barr, J. A. Reidy, N. A. Malek, C. C. Hodge, S. P. Caudill, J. W. Brock, L. L. Needham, and A. M. Calafat. 2004a. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ. Health Perspect. 112:331-338.
41. Silva, M. J., J. A. Reidy, A. R. Herbert, J. L. Preau Jr., L. L. Needham, and A. M. Calafat. 2004b. Detection of phthalate metabolites in human amniotic fluid. Bull. Environ. Contam. Toxicol. 72:1226-1231.
42. Silva, M. J., J. A. Reidy, E. Samandar, A. R. Herbert, L. L. Needham, and A. M. Calafat. 2005. Detection of phthalate metabolites in human saliva. Arch. Toxicol. 79:647-652.
43. St Pierre, M. V., M. A. Serrano, R. I. Macias, U. Dubs, M. Hoechli, U. Lauper, P. J. Meier, and J. J. Marin. 2000. Expression of members of the multidrug resistance protein family in human term placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279:R1495-R1503.
44. St Pierre, M. V., B. Ugele, L. Gambling, and K. T. Shiverick. 2002. Mechanisms of drug transfer across the human placenta - A workshop report. Placenta 23(Suppl A):S159-S164.
45. Swan, S. H., K. M. Main, F. Liu, S. L. Stewart, R. L. Kruse, A. M. Calafat, C. S. Mao, J. B. Redmon, C. L. Ternand, S. Sullivan, and J. L. Teague. 2005. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ. Health Perspect. 113:1056-1061.
46. Tomita, I., Y. Nakamura, Y. Yagi, and K. Tutikawa. 1986. Fetotoxic effects of mono-2-ethylhexyl phthalate (MEHP) in mice. Environ. Health Perspect. 65:249-254.
47. Young, A. M., C. E. Allen, and K. L. Audus. 2003. Efflux transporters of the human placenta. Adv. Drug Deliv. Rev. 55:125-132.